Ads
-
Related paper
- The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patients
- PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION
- Long-COVID sequelae are associated with oxidative stress in hemodialysis patients
- OXIDATIVE STRESS IN THE PATIENTS WITH CKD V STAGE AND ANEMIA WHO RECEIVE REPLACEMENT HEMODIALYSIS THARAPY
- Activation of oxidative stress, comorbidity and survival of end-stage renal disease patients treated with hemodialysis
- Relationship between Vitamin-D Receptor Gene Polymorphism FokI and Fetuin- A as A marker of Vascular Calcification in Egyptian Hemodialysis Patients
- Erythropoietin (Epo), Erythropoietin Receptor (EpoR) and Red Cell Development- Deciphering Molecular Connections
- Expression of Erythropoietin and Erythropoietin Receptor in Oral Squamous Cell Carcinoma
- Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?
- Predicting Resistance to Recombinant Human Erythropoietin Therapy in CKD Patients on Maintenance Hemodialysis